Tetracycline

目录号: GC37769纯度: >98.00%同义词: 四环素
Tetracycline(TC,四环素)是一种具有口服活性的广谱抗生素,可有效抑制革兰氏阳性菌、革兰氏阴性菌、衣原体、支原体和立克次体等细菌的活性。

Tetracycline
Cas No.: 60-54-8
规格价格库存数量操作
200mg¥450.00现货
1
1g¥720.00现货
1

文献被引

本产品暂无引用记录;以下为 GlpBio 产品在 Nature / Cell / Science 等顶刊的客户引用样例
  • Nature cover
    Nature
    641, 529–536 (2025)
  • Nature cover
    Nature
    628, 630–638 (2024)
  • Nature cover
    Nature
    632, 686–694 (2024)
  • Nature cover
    Nature
    618, 1017–1023 (2023)
  • Nature cover
    Nature
    610, 366–372 (2022)
  • Cell cover
    Cell
    187(9):2288-2304 (2024)
  • Cell cover
    Cell
    183(7):1867-1883 (2020)
  • Science cover
    Science
    388(6745) (2025)
  • Science cover
    Science
    387(6739) (2025)
  • Science cover
    Science
    387(6734) (2025)
  • Cell Research cover
    Cell Research
    35, 97–116 (2025)
  • Cell Research cover
    Cell Research
    34, 683–706 (2024)
  • Cell Research cover
    Cell Research
    33, 273–287 (2023)
  • Cell Research cover
    Cell Research
    33, 546–561 (2023)
  • Cell Research cover
    Cell Research
    33, 904–922 (2023)
  • Cell Research cover
    Cell Research
    31, 1291–1307 (2021)

产品描述 Description

Tetracycline (TC) is a broad-spectrum antibiotic with oral activity. It is effective against a variety of bacteria, including gram-positive and gram-negative bacteria, chlamydia, mycoplasma, and Rickettsia. It is used in the study of infections and can induce gene expression in the corresponding system[1-4].

Tetracycline (6.25-250 μM) was dose-dependent on NO synthetase activity and nitrite formation in J774 cells[5].

Tetracycline treatment delays the onset and slows the progression of diabetes in human amylin/islet amyloid polypeptide (hA/hIAPP) transgenic mice. Chronic oral administration of tetracycline (0.03 mg/ml in drinking water) from weaning enhances glycemic control and extends lifespan in hemizygous mice [6]. In a dog model of acute ischemia, 4mg/kg tetracycline injected 30 min prior to the occlusion improved the functional recovery from stunning of myocardium caused by ischemia[7]. Tetracycline injection at single doses of 1.5, 10, and 20 mg/kg significantly protected mice from a lethal intraperitoneal injection of LPS[8].

References:
[1]. Platt BN, Jacobs CA, et,al. Tetracycline use in treating osteoarthritis: a systematic review. Inflamm Res. 2021 Mar;70(3):249-259. doi: 10.1007/s00011-021-01435-4. Epub 2021 Jan 29. PMID: 33512569.
[2]. Chopra I, Roberts M. Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance. Microbiol Mol Biol Rev. 2001 Jun;65(2):232-60 ; second page, table of contents. doi: 10.1128/MMBR.65.2.232-260.2001. PMID: 11381101; PMCID: PMC99026.
[3]. Roberts MC. Tetracycline therapy: update. Clin Infect Dis. 2003 Feb 15;36(4):462-7. doi: 10.1086/367622. Epub 2003 Jan 28. PMID: 12567304.
[4]. Aiba A, Nakao H. Conditional mutant mice using tetracycline-controlled gene expression system in the brain. Neurosci Res. 2007 Jun;58(2):113-7. doi: 10.1016/j.neures.2007.01.009. Epub 2007 Jan 20. PMID: 17316857.
[5]. D'Agostino P, Arcoleo F, et,al. Tetracycline inhibits the nitric oxide synthase activity induced by endotoxin in cultured murine macrophages. Eur J Pharmacol. 1998 Apr 10;346(2-3):283-90. doi: 10.1016/s0014-2999(98)00046-6. PMID: 9652371.
[6]. Aitken JF, Loomes KM, et,al. Tetracycline treatment retards the onset and slows the progression of diabetes in human amylin/islet amyloid polypeptide transgenic mice. Diabetes. 2010 Jan;59(1):161-71. doi: 10.2337/db09-0548. Epub 2009 Sep 30. PMID: 19794060; PMCID: PMC2797917.
[7]. Kagawa N, Senbonmatsu TA, et,al. Tetracycline protects myocardium against ischemic injury. Front Biosci. 2005 Jan 1;10:608-19. doi: 10.2741/1557. PMID: 15569603.
[8]. Milano S, Arcoleo F, et,al. Intraperitoneal injection of tetracyclines protects mice from lethal endotoxemia downregulating inducible nitric oxide synthase in various organs and cytokine and nitrate secretion in blood. Antimicrob Agents Chemother. 1997 Jan;41(1):117-21. doi: 10.1128/AAC.41.1.117. PMID: 8980766; PMCID: PMC163671.

Tetracycline(TC,四环素)是一种具有口服活性的广谱抗生素,可有效抑制革兰氏阳性菌、革兰氏阴性菌、衣原体、支原体和立克次体等细菌的活性。Tetracycline可用于研究感染。Tetracycline可诱导相应系统的基因表达[1-4]

Tetracycline(6.25-250 μM)在J774细胞中剂量依赖性地降低了脂多糖刺激诱导的NO合成酶活性和亚硝酸盐的形成[5]

Tetracycline在人胰淀素/胰岛淀粉样多肽(hA/hIAPP)转基因小鼠中可延缓糖尿病的发生和进展。断奶后长期口服Tetracycline(0.03 mg/ml drinking water)可改善半合子小鼠的血糖控制和寿命[6]。在狗急性缺血模型中,血管闭塞前30分钟注射4mg/kg Tetracycline可改善缺血引起的心肌休克的功能恢复[7]。注射单剂量Tetracycline(1.5, 10 and 20 mg/kg)的小鼠可明显避免腹腔注射致死性LPS[8]

实验参考方法 Experimental Reference Method

Cell experiment [1]:

Cell lines

J774 macrophage

Preparation Method

Cells were cultured in medium stimulated with lipopolysaccharide (1 μg/ml) and treated with varying doses of tetracycline.

Reaction Conditions

6.25-250 μM; 6h

Applications

Tetracycline reduced lipopolysaccharide-stimulated inducible NO synthase activity and nitrite formation in a dose-dependent manner.
Animal experiment [2]:

Animal models

Adult mongrel dogs (acute ischemia model)

Preparation Method

Saline or tetracycline (4 mg/kg in saline) was administered intravenously at a volume of 0.5 mL/kg, 30 minutes before the ligation. The ligature around the coronary artery was tightened for 20 minutes and then released to allow reperfusion.

Dosage form

4 mg/kg; i.p

Applications

Tetracycline, injected 30 minutes before the occlusion, enhanced the functional recovery of the myocardium from stunning caused by ischemia.

References:
[1]. D'Agostino P, Arcoleo F, et,al. Tetracycline inhibits the nitric oxide synthase activity induced by endotoxin in cultured murine macrophages. Eur J Pharmacol. 1998 Apr 10;346(2-3):283-90. doi: 10.1016/s0014-2999(98)00046-6. PMID: 9652371.
[2]. Kagawa N, Senbonmatsu TA, et,al. Tetracycline protects myocardium against ischemic injury. Front Biosci. 2005 Jan 1;10:608-19. doi: 10.2741/1557. PMID: 15569603.

产品文档 Product Documents

Purity:>98.00%

化学性质Chemical Properties

CAS 号
60-54-8
同义词
四环素
SMILES
O=C(C(C1=O)=C(O)[C@@H](N(C)C)[C@]2([H])C[C@]3([H])[C@](C)(O)C4=C(C(C3=C(O)[C@@]21O)=O)C(O)=CC=C4)N
分子式
C22H24N2O8
分子量
444.43 g/mol
溶解性
DMSO: 125 mg/mL (281.26 mM)
保存条件
Store at 2-8°C,unstable in solution, ready to use.
General tips
请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。
储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。
为了提高溶解度,请将管子加热至 37°C,然后在超声波浴中震荡一段时间。
Shipping Condition
评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备 RT,或根据请求配备蓝冰。

计算工具摩尔浓度 / 稀释 / 分子量 / 单位换算 / 体内配方 / 溶解度

g/mol